ABL Bio ranked among the top searched stocks for 3 days in the past month.

As of 10:33 AM on the 11th, ABL Bio is trading at 28,950 KRW, down 0.34% from the previous day. This represents a 59.07% increase compared to May 27. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.

Today, foreigners have sold a net 26,000 shares of ABL Bio, while institutions have bought a net 6,000 shares, according to provisional data. Over the past 5 days, individual investors have bought a net 483,165 shares, foreigners have bought a net 168,147 shares, and institutions have sold a net 528,475 shares.

On June 10, ABL Bio was in the spotlight in the market for discussions on the technology transfer of the "blood-brain barrier (BBB)" platform.



[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing